Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Management of Menorrhagia

Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation

Summary:

The management of uterine bleeding in female transplant patients over a 3-year period at our institution was reviewed. A total of 33 females who had undergone allogeneic hematopoietic stem cell transplant were identified as having received gynecologic consultation for the diagnosis of menorrhagia. Hormone therapy achieved a resolution of symptoms in 32 (97%) of the patients, and 26 (79%) required only one hormone regimen. Following resolution of symptoms, transition to standard-dose oral contraceptive pills as maintenance therapy prevented recurrent menorrhagia due to high circulating estrogen levels. Alternatives for patients who are unable to tolerate oral administration and those with hepatotoxicity are also discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Dowsett M, Richner J . Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in premenopausal breast cancer patients. Oncology 1991; 48: 215–220.

    Article  CAS  Google Scholar 

  2. Sanders JE, Buckner CD, Leonard JM et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983; 36: 252–255.

    Article  CAS  Google Scholar 

  3. Rosenfeld JA . Treatment of menorrhagia due to dysfunctional uterine bleeding. Am Fam Physician 1996; 53: 165–172.

    CAS  PubMed  Google Scholar 

  4. Irvine GA . Medical management of dysfunctional uterine bleeding. Baillière's Clin Obstet Gynecol 1999; 13: 189–202.

    CAS  Google Scholar 

  5. Munro MG . Dysfunctional uterine bleeding: advances in diagnosis and treatment. Curr Opin Obstet Gynecol 2001; 13: 475–489.

    Article  CAS  Google Scholar 

  6. Reich H, Ribeiro SC, Vidali A . Hysterectomy as treatment for dysfunctional uterine bleeding. Best Pract Res Clin Obstet Gynecol 1999; 13: 251–269.

    Article  CAS  Google Scholar 

  7. Laufer MR, Townsend NL, Parsons KE et al. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. J Reprod Med 1997; 42: 537–541.

    CAS  PubMed  Google Scholar 

  8. Ghalie R, Porter C, Radwanska E et al. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 1993; 42: 350–353.

    Article  CAS  Google Scholar 

  9. Chiusolo P, Salutari P, Sica S et al. Lutenizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation. Bone Marrow Transplant 1998; 21: 821–823.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Amsterdam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amsterdam, A., Jakubowski, A., Castro-Malaspina, H. et al. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 34, 363–366 (2004). https://doi.org/10.1038/sj.bmt.1704577

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704577

Keywords

This article is cited by

Search

Quick links